Alan P. Lyss, MD

At a SITC summit, stakeholders identified administrative, staffing, and other barriers that impede progress in clinical cancer research.

New data highlight the high cost of targeted oral anticancer medicines for patients with Medicare Part D coverage.

New research suggests aspirin may lower the risk for gastric adenocarcinoma in women but not in men.